Neogen Chemicals Limited has informed the Exchange about General Updates
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Neogen Chemicals, at its meeting on July 12, 2025, approved raising up to Rs. 200 crores through the issue of secured, listed, rated, redeemable, non-convertible debentures (NCDs) on a private placement basis, in one or more tranches, to be listed on BSE. The NCDs will have a tenure of up to 36 months, with monthly interest payments and a subservient charge created via hypothecation and mortgage in favour of the Debenture Trustee. In case of default, an additional 2% p.a. interest over the coupon rate will be charged. Separately, the company disclosed that BSE levied a fine of Rs. 3,61,080 (including GST) for non-compliance with Regulation 17(1A) of the Listing Regulations, relating to the specific mention of the regulation in the special resolution for re-appointment of Independent Director Prof. Ranjan Kumar Malik who attained age 75. The fine was paid within 15 days, and a similar fine from NSE was paid earlier. The company has initiated a postal ballot process to obtain the required shareholder approval for continuation of the director.
The Rs. 200 crore NCD raise will increase the company's debt but provides additional capital for business needs within the existing borrowing limits. The BSE fine is a minor one-time, non-material compliance cost and is unlikely to affect stock price; the company has already taken corrective steps via postal ballot.